Application value of metagenomics next-generation sequencing in the diagnosis of respiratory virus infection after congenital heart surgery
- PMID: 38455752
- PMCID: PMC10915445
- DOI: 10.21037/tp-23-341
Application value of metagenomics next-generation sequencing in the diagnosis of respiratory virus infection after congenital heart surgery
Abstract
Background: Timely and accurate pathogen diagnosis can be challenging in children who contract a respiratory virus following congenital heart surgery (CHS). This often results in suboptimal drug use and treatment delays. Metagenomics next-generation sequencing (mNGS) is a swift, efficient, and unbiased method for obtaining microbial nucleic acid sequences. This technology holds promise as a comprehensive diagnostic tool, especially for pathogens undetectable by traditional methods. However, the efficacy of mNGS in the context of congenital heart disease infections remains uncertain. This study aimed to explore the diagnostic value of mNGS for respiratory virus infections post-CHS.
Methods: We conducted a retrospective analysis of patients who developed respiratory tract infections post-CHS and were admitted to our cardiac center between July 2021 and December 2022. The patients were categorized into the following two groups based on the diagnostic method used: (I) the mNGS group (comprising 62 patients); and (II) the conventional microbiological test (CMT) group (comprising 70 patients). Bronchoalveolar lavage fluid (BALF) samples from these patients were tested to identify pathogens.
Results: The mNGS group had significantly higher detection rates for both viral infections and mixed viral infections than the CMT group (56.45% vs. 17.14%, P<0.001, and 80.00% vs. 16.67%, P<0.001, respectively). In the mNGS group, 19.35% of the patients received antiviral therapy, and 61.29% received an anti-infective regimen adjustment. Conversely, in the CMT group, only 4.29% received antiviral therapy, and 28.57% received an anti-infective regimen adjustment. A higher percentage of patients showed improved respiratory symptoms in the mNGS group than the CMT group (74.19% vs. 44.29%, P=0.001). Additionally, the mNGS group had a shorter duration of mechanical ventilation and a reduced length of stay in the cardiac intensive care unit than the CMT group (P=0.012).
Conclusions: Using mNGS for BALF enhances the detection of respiratory viral infections and coexisting viral infections post-CHS. This facilitates more precise treatment strategies and could potentially lead to improved patient outcomes.
Keywords: Metagenomics next-generation sequencing (mNGS); congenital heart surgery (CHS); respiratory infection; virus.
2024 Translational Pediatrics. All rights reserved.
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://tp.amegroups.com/article/view/10.21037/tp-23-341/coif). The authors have no conflicts of interest to declare.
Figures
Similar articles
-
A single-center, retrospective study of hospitalized patients with lower respiratory tract infections: clinical assessment of metagenomic next-generation sequencing and identification of risk factors in patients.Respir Res. 2024 Jun 20;25(1):250. doi: 10.1186/s12931-024-02887-y. Respir Res. 2024. PMID: 38902783 Free PMC article.
-
[Diagnostic value of detection of pathogens in bronchoalveolar lavage fluid by metagenomics next-generation sequencing in organ transplant patients with pulmonary infection].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021 Dec;33(12):1440-1446. doi: 10.3760/cma.j.cn121430-20211008-01439. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2021. PMID: 35131010 Chinese.
-
Effect of metagenomic next-generation sequencing on clinical outcomes in adults with severe pneumonia post-cardiac surgery: a single-center retrospective study.Sci Rep. 2024 Nov 21;14(1):28907. doi: 10.1038/s41598-024-79843-9. Sci Rep. 2024. PMID: 39572618 Free PMC article.
-
Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections.J Adv Res. 2021 Sep 29;38:201-212. doi: 10.1016/j.jare.2021.09.012. eCollection 2022 May. J Adv Res. 2021. PMID: 35572406 Free PMC article. Review.
-
Application of Second-Generation Sequencing Technology in Lower Respiratory Tract Infection.J Clin Lab Anal. 2024 Aug;38(15-16):e25090. doi: 10.1002/jcla.25090. Epub 2024 Aug 19. J Clin Lab Anal. 2024. PMID: 39158216 Free PMC article. Review.
References
LinkOut - more resources
Full Text Sources